Mexico Urinalysis Market (2024-2029)
The Mexico Urinalysis Market was valued at $38.3 Million in 2024 and projected to reach to $61 Million by 2029, representing a compound annual growth rate of 9.7%. Mexico's urinalysis market is positioned for sustained growth through 2029, driven by ongoing healthcare infrastructure modernization and increased diagnostic testing adoption.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Mexico Urinalysis Market Trends and Insights
- This expansion reflects Mexico's increasing healthcare infrastructure investments and rising demand for diagnostic testing services across both public and private sectors.
- Mexico's market growth trajectory is driven by expanding patient populations, improved access to laboratory facilities, and growing awareness of preventive healthcare measures. The 9.7% compound annual growth rate in Mexico underscores the country's commitment to modernizing its diagnostic capabilities and strengthening primary care services.
- Mexico's urinalysis market benefits from demographic trends, including an aging population and rising prevalence of chronic diseases requiring routine screening.
- By 2029, Mexico is expected to solidify its position as a key market for urinalysis diagnostics in Latin America, supported by ongoing healthcare reforms and increased laboratory automation adoption..
Key Market Statistics
- CAGR (2024-2029) 9.7% CAGR
- Market Size, 2024 ~USD 38.3 Million
- Forecast, 2029 ~USD 61 Million
- Country Mexico
Mexico Urinalysis Market Overview
Market Valuation Growth :
Mexico's urinalysis market is valued at $38.3 million in 2024, with a projected CAGR of 9.7% through 2029, reaching $61.0 million by forecast end.
Healthcare Infrastructure Expansion :
Mexico is experiencing significant investments in healthcare infrastructure, driving increased adoption of diagnostic testing services across both public and private medical facilities.
Dual Sector Demand :
Growth is fueled by rising demand for urinalysis testing in both Mexico's public healthcare system and expanding private diagnostic centers, reflecting broader healthcare accessibility improvements.
Patient Population Dynamics :
Expanding patient populations and improved healthcare accessibility in Mexico are creating sustained demand for routine diagnostic testing, including urinalysis services.
Mexico Urinalysis Market Dynamics
- The country's expanding middle class and improved healthcare accessibility are creating new opportunities for diagnostic service providers.
- Both public sector initiatives and private healthcare expansion are contributing to market expansion, with diagnostic testing becoming increasingly integrated into routine patient care protocols across Mexican healthcare facilities. The market's 9.7% CAGR reflects Mexico's commitment to enhancing diagnostic capabilities and preventive healthcare measures.
- Investment in laboratory equipment, trained personnel, and testing protocols will be critical to capturing growth opportunities.
- As Mexico continues to strengthen its healthcare system, urinalysis testing demand is expected to remain robust, particularly in urban centers and emerging secondary markets..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Mexico's urinalysis market is valued at $38.3 million in 2024 and will reach $61.0 million by 2029, representing a 9.7% CAGR.
- Mexico's market growth is driven by healthcare infrastructure expansion, aging demographics, and increased chronic disease prevalence.
- Mexico's diagnostic sector is benefiting from laboratory automation and modernization initiatives across public and private healthcare systems.
- Mexico's strategic position in Latin America positions it as a high-growth market for urinalysis diagnostics through 2029.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
Mexico Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
MEXICO: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 18.1 | 18.8 | 19.7 | 20.9 | 22.2 | 23.9 | 26 | 28.7 | 7.7 |
| HOME CARE SETTINGS | 12.3 | 12.8 | 13.5 | 14.3 | 15.3 | 16.6 | 18.2 | 20.2 | 8.4 |
| HOSPITALS & CLINICS | 14.8 | 15.9 | 17.3 | 19 | 21 | 23.5 | 26.6 | 30.5 | 12 |
| RESEARCH LABORATORIES & INSTITUTES | 3.3 | 3.4 | 3.5 | 3.7 | 3.9 | 4.2 | 4.6 | 5 | 7.1 |
| TOTAL | 48.49 | 50.91 | 54.05 | 57.88 | 62.5 | 68.29 | 75.44 | 84.31 | 9.3 |
Target Audience
- Diagnostic Equipment Manufacturers : Need Mexico-specific market data to assess demand for urinalysis analyzers, reagents, and testing equipment across public hospitals and private diagnostic laboratories.
- Healthcare Service Providers : Require market insights to evaluate expansion opportunities in Mexico's diagnostic testing sector and understand patient demand patterns for urinalysis services.
- Medical Laboratory Operators : Seek detailed market analysis to identify growth opportunities, competitive positioning, and investment requirements for establishing or expanding laboratory operations in Mexico.
- Healthcare Investors & PE Firms : Need validated market sizing and growth projections for Mexico to evaluate investment opportunities in diagnostic service providers and healthcare infrastructure companies.
- Pharmaceutical & Reagent Suppliers : Require Mexico market data to forecast demand for urinalysis reagents, consumables, and related products across the country's expanding diagnostic testing infrastructure.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for Mexico's urinalysis market ($38.3M in 2024) with verified CAGR projections through 2029, enabling accurate business planning and investment decisions.
- Competitive Landscape Intelligence : Understand Mexico-specific market dynamics, including public vs. private sector opportunities, regional variations, and competitive positioning within Latin America's diagnostic testing sector.
- Strategic Market Entry Planning : Access detailed insights on Mexico's healthcare infrastructure investments, regulatory environment, and distribution channels to develop targeted market entry and expansion strategies.
- Revenue Forecasting Accuracy : Leverage Mexico-specific forecast data through 2029 to project revenue potential, allocate resources effectively, and benchmark performance against market growth trajectories.
- Stakeholder Alignment : Present credible, market-validated data to investors, partners, and internal teams regarding Mexico's urinalysis market opportunity and growth potential in the Latin American healthcare sector.
Frequently asked questions
What is the current size of Mexico's urinalysis market?
Mexico's urinalysis market was valued at $38.3 million in 2024 and is projected to grow to $61.0 million by 2029.
What is the growth rate of Mexico's urinalysis market?
Mexico's urinalysis market is growing at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2029.
What factors are driving growth in Mexico's urinalysis market?
Mexico's market growth is driven by healthcare infrastructure investments, an aging population, rising chronic disease prevalence, and increased laboratory automation adoption.
How does Mexico's urinalysis market compare to other Latin American countries?
Mexico represents a significant market within Latin America, with strong growth momentum supported by healthcare modernization and demographic trends favoring diagnostic testing expansion.
What is the forecast for Mexico's urinalysis market by 2029?
Mexico's urinalysis market is forecast to reach $61.0 million by 2029, up from $38.3 million in 2024, reflecting sustained healthcare sector development.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
